Adverse effects induced by second-line antituberculosis drugs: an update based on last WHO treatment recommendations for drug-resistant tuberculosis

Department of Morpho-Functional Sciences II – Pharmacology and Clinical Pharmacology, at “Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania

Elena Cătălina Lupușoru

“Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania

Department of Morpho-Functional Sciences II – Pharmacology and Clinical Pharmacology, at “Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania

Metrics

Articles in this issue

DOI: https://doi.org/10.2478/pneum-2022-0029 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993

Journal RSS Feed

Language: English

Page range: 117 - 126

Published on: Oct 21, 2022

Published by: Romanian Society of Pneumology

In partnership with: Paradigm Publishing Services

Publication frequency: Volume open

Keywords:

DR-TB,

Related subjects:

Clinical medicine, other,

Internal medicine,

Pneumology

© 2022 Ionela-Alina Grosu-Creangă, Antigona Carmen Trofor, Radu Adrian Crișan-Dabija, Daniela Robu-Popa, Cristina Mihaela Ghiciuc, Elena Cătălina Lupușoru, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 70 (2021): Issue 3 (October 2021)